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Abstract
Although Wnt signaling has been shown to be important for embryonic morphogenesis and cancer pathogenesis of several
tissues, its role in prostatic development and tumorigenesis is not well understood. Here we show that Wnt signaling
regulated prostatic epithelial branching morphogenesis and luminal epithelial cell differentiation in developing rat prostate
organ cultures. Specifically, Wnt signaling regulated the proliferation of prostate epithelial progenitor cells. Assessment of
the expression levels of a Wnt pathway transcriptional target gene, Axin2, showed that the Wnt pathway was activated in
the developing prostate, but was down-regulated in the adult. Castration resulted in an upregulation of Axin2 whereas
androgen replacement resulted in a down regulation of Axin2. Such dynamic changes of Wnt activity was also confirmed in
a BAT-gal transgenic mouse line in which b-galactosidase reporter is expressed under the control of b-catenin/T cell factor
responsive elements. Furthermore, we evaluated the role of Wnt signaling in prostate tumorigenesis. Axin2 expression was
found upregulated in the majority of human prostate cancer cell lines examined. Moreover, addition of a Wnt pathway
inhibitor, Dickkopf 1 (DKK1), into the culture medium significantly inhibited prostate cancer cell growth and migration.
These findings suggest that Wnt signaling regulates prostatic epithelial ductal branching morphogenesis by influencing cell
proliferation, and highlights a role for Wnt pathway activation in prostatic cancer progression.
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Introduction
The Wnt signaling pathway is crucial in a variety of biological
process including neural patterning, planar polarity, stem cell
maintenance and cell differentiation [1]. This has been demon-
strated in a number of systems, via genetic and biochemical
approaches. The Wnt signaling is initiated by extracellular
proteins, i.e., Wnts, through binding to their respective frizzled
family of receptors. The signal is then transduced to b-catenin via a
cascade of signal transducing molecules in the cytoplasm. b-catenin
then enters into the nucleus, forms a complex with TCF and
transactivates the downstream target genes that regulate or
participate in various processes. The complexity of signaling arises
in part from the multitude of components in this pathway including
for example 19 human Wnt ligands, 1 Wnt inhibitory factor (WIF),
5 secreted frizzled related proteins (SFRPs) that can sequester Wnt
ligands from binding to their cognate receptors, 2 low density
lipoprotein receptor-related proteins (LRP5/6) and 4 Dickkopf
(Dkk) proteins that modulate the activity of frizzled receptors [1,2].
In the canonical Wnt pathway, stabilization and translocalization
of b-catenin to the nucleus is a critical step of Wnt signaling
activation. In absence of Wnt ligand binding, b-catenin is targeted to
degradation via its interaction with the adenomatosis polyposis coli
(APC) protein and the Wnt signaling is minimally activated. When
APC is mutated, b-catenin accumulates in the nucleus and Wnt
signaling is constitutively active [1]. The Wnt signaling downstream
program is poorly understood, and a very useful downstream gene
specific for this pathway is Axin 2, which upon transcription and
translation, acts as a negative feedback regulator of the Wnt
siginaling pathway, by helping direct b-catenin for degradation in
the proteasome [3,4]. Stabilization of b-catenin protein and
elevation of Axin2 transcript are considered indicators of Wnt
pathway activation [4].
Dysregulation of Wnt signaling is also associated with cancer
pathogenesis of various tissues [5,6]. Genetic alterations in the
APC genes causes predisposition for colorectal cancer (Groden,
Cell 1991), and the tumor suppressor function of APC/oncogenic
effect of Wnt pathway is clearly demonstrated in APCmin
transgenic mice where numerous adenomas form in the intestine
[7]. The role of Wnt pathway in prostate tumorigenesis has
recently received increased attentions but is still not well
understood. Recent studies reported that certain Wnt ligands
such as Wnt1 are expressed in prostate cancer cell lines and appear
to be elevated in some human prostate tumor tissues [8]. Specific
Wnt pathway inhibitors such as WIF1 appear to be down-
regulated in a considerable percentage of prostate cancer samples
[9]. Prostate-specific deletion of APC gene in mice results in
formation of adenocarcinoma [10]. In addition, interaction
between b-catenin and the androgen receptor (AR) has been
shown to enhance AR-mediated transcription [11], which plays a
critical role during prostatic cancer progression. Elucidating how
Wnt signaling regulates prostatic development and tumorigenesis
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the treatment of prostate cancer.
In an effort to understand the role of Wnt signaling in prostatic
epithelial development, we performed organ cultures of developing
prostates prepared from early postnatal rats to determine the effects
of modulation of the Wnt signaling pathway on prostatic epithelial
branching morphogenesis. We found that Wnt signaling regulated
prostatic epithelial cell differentiation through influencing the
proliferation of prostatic epithelial progenitor cells. In addition,
TaqMan RT-PCR analysis revealed that several commonly studied
prostate cancer cell lines and xenografts exhibited activation of the
Wnt pathway. Moreover, Dickkopf1 (DKK1), a Wnt pathway
inhibitor [12–14], significantly inhibited prostate cancer cell growth
and migration. These findings together suggest that activation of the
Wnt pathway plays a crucial role during prostatic development, and
regrowth and that inhibiting the Wnt pathway might be of
therapeutic value in the management of prostate cancer progression.
Results
Wnt signaling regulates prostatic epithelial branching
morphogenesis
Prostatic epithelial branching morphogenesis in the rodent occurs
mainly after birth by expansion and further branching from the
epithelial primodia [15,16]. This process can be recapitulated in a
convenient organ culture system [17,18]. To examine whether Wnt
signaling plays a role in prostatic epithelial branching morphogen-
esis, we treated organ cultures of postnatal day 2 (P2) rat ventral
prostates with a Wnt ligand, Wnt3a, or a potent Wnt signaling
inhibitor, DKK1 [12]. As shown in Fig. 1, the prostate in control
cultures showed extensive branching with not only primary and
secondaryductsbut alsotertiary,finebranchesafter7 daysinculture
(Fig. 1A). However, the tissue in the cultures treated with Wnt3a at a
concentration of 50 nM displayed blunted, enlarged ductal tips
(arrow in Fig. 1B) and a reduced number of tertiary, fine branches.
Prostates treated with DKK1 at 400 nM, the prostates appeared
smaller in size and had fewer epithelial branches. However, in
contrast to Wnt3a-treated prostates, DKK1 treated prostates lacked
enlarged ductal tips (Fig. 1C). Quantification of these cultures by
measuring the diameters of the cultured prostates and the ductal tips
and counting the branching pointsoftheseculturesshowed statistical
differences between the control cultures and thecultures treated with
Wnt3a in all 3 aspects (Fig. 1D-F). These results suggest that both
activation and inhibition of Wnt signaling affect adversely prostatic
epithelial branching morphogenesis, and highlight the importanceof
precisely-regulated Wnt signaling for the proper development of the
prostate.
Wnt signaling influences cell proliferation and
differentiation in the developing prostate epithelium
Prostatic epithelium is mainly composed of basal and luminal
cells along with a minor population of neuroendocrine cells [19].
Figure 1. Wnt3a and DKK1 regulate prostatic epithelial branching morphogenesis. Whole mount ventral prostates were prepared from P2
rats and maintained for 7 days in serum-free medium in the absence (A) or presence of 50 nM of Wnt3a (B) or 400 nM of DKK1 (C). Similar patterns
were consistently seen in 3 repeat experiments of 5–6 prostate organs per group in each individual experiment. Note that addition of either Wnt3a or
DKK1 to the culture resulted a change in epithelial branching morphogenesis. Quantification of the cultures by measuring the diameter of the
cultured prostates (D) and the ductal tips (E) using Axiovision software and the branching points (F) were done by analyzing 4 randomly selected
cultures per group. Data are expressed as mean + SEM (t-test, compared to control cultures). Bar, 400 mm.
doi:10.1371/journal.pone.0002186.g001
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and are believed to contain the progenitor cell population [21].
The luminal cells express CK8 or CK18, and are generally post-
mitotic and terminally differentiated cells. In rodents, nearly all
epithelial cells are progenitor cells and are proliferating until P5
when some of the progenitors undergo terminal mitosis and
differentiate into luminal cells that express only CK8 or CK18
[19]. To determine if modulation of Wnt signaling influences the
differentiation of progenitors into luminal cells, we performed
immunohistochemistry on sections of the prostate organ cultures
using basal and luminal cell markers, p63 and CK8, respectively.
As shown in Fig. 2, more p63 positive cells were seen in the ductal
region of Wnt3a-treated cultures (Fig. 2B) than the control cultures
(Fig. 2A). In contrast, fewer p63 positive cells were present in
DKK1-treated cultures (Fig. 2C). The cells that were labeled by
DAPI nuclear staining in the epithelium, but negative for p63,
represent those differentiated luminal cells, which was confirmed
by CK8 immunostaining (data not shown). Cell counts from
randomly selected cultures of the 3 groups revealed that the
percentage of basal cells over the total epithelial cell population
within a given individual ductal unit was significantly higher in the
Wnt3a-treated cultures as compared with control cultures
(Fig. 2D). In contrast to Wnt3a action, the ratios of basal cells
vs. total epithelial cells were significantly lower in DKK1-treated
cultures than that in control cultures (Fig. 2C). Immunostaining
using a CK8 antibody showed a complementary pattern: Wnt3a
resulted in a reduction in the number of luminal cells whereas
DKK1 led to an enhanced number of luminal cells (data not
shown). The change in basal vs. total epithelial cells were not
attributable to cell death as TUNEL labeling only detected
minimal, background signals with no difference among the three
groups of cultures (data not shown).
Given that Wnt3a and DKK1 treatments led to an enhanced
and decreased number of p63 positive cells, respectively, which are
mainly composed of progenitors at this early developmental stage,
we sought to determine whether Wnt3a and DKK1 would affect
the proliferation of progenitor cells in these prostate organ cultures
using bromo-deoxyuridine (BrdU) and Ki67 immunohistochemis-
try. As shown in Figure 3, after a 3- day treatment, more
proliferating cells were observed in cultures treated with Wnt3a
(Fig. 3C,D), and fewer proliferating cells in cultures treated with
DKK1 (Fig. 3E,F), as compared to the control cultures (Fig. 3A,B).
Cell counts performed from randomly selected fields indicated that
there was a 1.63-fold increase in the number of Ki67 positive cells
in Wnt3a-treated prostate organs compared to control cultures
(Fig. 3G). In contrast, there was a significant decrease in the
number of Ki67 positive cells in DKK1-treated prostate organs
(Fig. 3G). Consistent with the BrdU incorporation assays, our
Ki67 immunohistochemistry in the 7-day cultures also showed
similar cell proliferation-enhancing and inhibiting effects by
Wnt3a and DKK1, respectively (Fig. 3H). To understand how
cell proliferation is regulated by Wnt signaling during prostate
development, we examined expression patterns of several cyclin
genes in a separate microarray study of developing mouse
prostates. We found that cyclin B2 expression was significantly
higher at P4 than P19 and 10 weeks old mice (approximately 4-
and 8-fold, respectively) and that the association of cyclin B2 with
early development was much stronger than those of other cyclins
(data not shown). To confirm whether the elevated proliferation,
based on Ki67 staining, seen in the organ culture might be partly
mediated by cyclin B2, we performed TaqMan RT-PCR analysis
of these cultures. As shown in Fig. 3I, the expression of cyclin B2
was approximately 118.8-fold higher and about 4.5-fold lower
in the organ cultures treated with Wnt3a and DKK1,
Figure 2. Wnt signaling prevents prostatic epithelial cell
differentiation. (A,B,C) p63 immunocytochemistry (red) of the
P2 rat ventral prostate organ cultures maintained for 7 days in
the absence (A) or presence of 50 nM of Wnt3a (B) or 400 nM of
DKK1 (C). The tissue sections were counterstained with DAPI (blue).
While p63 positive cells (purple) represent basal cells where progenitor
cells reside, the blue cells (arrows) that are negative to p63 in the
epithelium are differentiated luminal cells. (D) Quantification of p63
positive cells over total epithelial cells. Data were collected from
randomly selected 22–27 ductal units from sections of the organ
cultures per group and are expressed as mean + SEM (t-test). Note that
while Wnt3a led to a significant increase in the number of basal cells,
DKK1 resulted in a reduction in basal cells. Bar, 50 mm for A-C.
doi:10.1371/journal.pone.0002186.g002
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signaling regulates the terminal differentiation of basal cells into
luminal cells by controlling the proliferation and/or maintenance
of epithelial progenitor cells.
Dynamic changes of Wnt signaling activation during
prostatic development, after castration and following
androgen replacement
To provide further supportive evidence for the role of Wnt
signaling in the maintenance of prostate epithelial progenitors, we
performed quantitative RT-PCR using Axin2 as an indicator for
activation of Wnt signaling with prostate tissue prepared at various
time points of development. We found that Axin2 levels were the
highestatP2butdeclinedovertimeastheprostatematured(Fig.4A).
These data suggest that Wnt signaling is more active at the early
stages of developing prostates, consistent with a higher progenitor
cell population than in fully developed prostates where the majority
of the epithelial cells are terminally differentiated luminal cells.
Previous studies have shown that the portion of the basal cell
compartment over the total epithelial cells in the prostate
epithelium is altered following castration and hormonal replace-
ment [22]. Castration-induced androgen withdrawal is known to
deplete approximately 90% of the epithelial content [23] and
results in enrichment of the basal/progenitor cell population.
Androgen replacement in turn leads to proliferation of the
progenitor cells and their differentiation into luminal cells,
resulting in prostate re-growth back to its normal size [24]. We
performed quantitative real-time RT-PCR to compare expression
levels of Axin2 in prostates harvested from normal mice, mice after
3 days and 17 days following castration and mice after 3 days of
testosterone replacement following castration. As shown in Fig. 4B,
Axin2 levels were 1.5-fold and 1.7-fold higher in prostates 3 and
17 days following castration, respectively, but declined 3 days after
testosterone replacement. These data from both developing and
regrowing prostates indicate that Wnt signaling is positively
correlated to basal cell number and inversely correlated with
differentiation of progenitors into luminal cells in prostates.
Figure 3. Activation of Wnt signaling enhances prostate epithelial cell proliferation. (A-F) Shown are anti-BrdU antibody (B,D,F) and DAPI
(A,C,E) double labeling of the P3 rat ventral prostate organ cultures maintained for 3 days in the absence (A,B) or presence of 50 nM of Wnt3a (C,D) or
400 nM of DKK1(E,F). (G). Quantification of BrdU-positive cells in a given visual field of 434 mm6322 mm. (H) Quantification of Ki67-positive cells in the
P2 prostate cultures maintained for 7 days, which was normalized to the control cultures. Cell counts (for G and H) were performed from randomly
selected visual fields of 5 organ cultures per group and data were expressed as mean+SEM (t-test). Note that while Wnt3a significantly enhanced
progenitor cell proliferation, DKK1 inhibited progenitor cell proliferation. (I). Expression level change of cyclin B2 in P2 rat prostate organ cultures..
Data were collected from 4 organ cultures maintained for 2 days per group and are expressed as mean+SEM (t-test). Note that expression of cyclin B2
was upregulated by wnt3a, but down-regulated by DKK1. Bar, 100 mm for A-F.
doi:10.1371/journal.pone.0002186.g003
Wnt and Prostate Development
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galactosidase reporter is expressed under the control of b-catenin/
Tcell factor responsive elements [25]. This mouse line has been
shown to be bona fide in vivo indicators of Wnt/b-catenin signaling,
allowing visualization of the general status of Wnt activation in
cells in a given tissue. Examination of tissue sections prepared from
prostates at different stages including P5 (developing prostates,
Fig. 5A-C), adult (mature prostates, Fig. 5D-F)), post-castration
(Fig. 5G-I) and following androgen replacement (Fig. 5J-L),
indicated that the number of b-galactosidase-positive cells was
much higher in developing prostates, than adult prostates
(28.766.9/duct, n=10 vs. 1.9260.4/duct, n=13, Fig. 5M).
Castration led to an elevated number of b-galactosidase-positive
cells (5.260.7/duct, n=13), but androgen replacement resulted in
a lower number that was equivalent to the normal level in adult
prostates (2.360.5/duct, n=15, Fig. 5M). In addition, We found
that Wnt activity was exclusively seen in epithelial cells, mainly in
basal cell compartment where progenitor cells reside. In addition,
double labeling of these tissue sections with anti-p63 antibody, a
basal cell marker, and anti-b-galactosidase antibody revealed that
in the adult, the vast majority of b-galactosidase-positive cells were
co-labeled with anti-p63 antibody (arrows in Fig. 5A-L and N),
although in postnatal prostates, there were noticeable number of
b-galactosidase-positive cells in luminal cell layer, which could be
due to a possibility of delayed degradation of b-galactosidase
activity in the terminally mitotic cells that exited cell cycle to
differentiate into luminal cells. Therefore, these findings not only
confirm the dynamic changes of Wnt activity during prostate
development and regrowth obtained by TaqMan RT-PCR
analysis of Axin2 expression, but also provide additional support
for association of Wnt signaling with prostate basal cells where
progenitor cells are generally believed to reside.
Inhibition of Wnt signaling leads to suppression of cell
proliferation and migration of prostate cancer cells
Aberrant Wnt signaling has been observed in many tumors
[5,6]. To determine whether Wnt signaling plays a role in prostatic
tumorigenesis and tumor progression, we assessed the Wnt
signaling status in human prostate cancer cell lines and 2 human
prostate tumor xenografts by measuring expression levels of Axin2.
As shown in Fig. 6, quantitative RT-PCR analysis revealed that
Axin2 was expressed at higher levels in PC3, DU145 and LNCaP
cell lines and human prostate tumor xenograft samples (LuCaP35
and LuCaP77) [26], than normal or non-tumorigenic human
prostate epithelial cells such as PrEC and BPH1 cells [27]. Hence,
Wnt signaling is upregulated in prostate cancer cells compared to
normal prostate epithelial cells.
We next assessed whether Wnt3a or DKK1 treatment would
affect the growth of PC3 cells. By measuring cell proliferation
using
3H thymidine incorporation, we found that treatment of the
cultures with Wnt3a resulted in a significant increase in cell
proliferation (Fig. 7A). In contrast, DKK1 treatment reduced cell
proliferation in a dose-dependent manner (Fig. 7A). Similar results
were also observed in LNCaP cells (data not shown).
To examine whether Wnt signaling also affects prostate cancer
cell migration or cell motility, we performed cell migration
experiments with PC3 cells. As shown in Fig. 7B, addition of
Wnt3a into the culture medium led to an enhanced number of
migrated cells, whereas DKK1 inhibited cell migration, compared
to the control culture. In contrast, treatment of BPH1 cells in
which expression Axin2 was low or not detectable (Fig. 6) with
DKK1, no inhibitory effects on cell migration was seen (data not
shown). On the other hand, either trypan blue staining or FACS
sorting using annexin 5 immunostaining did not reveal enhanced
cell death in the DKK1-treated cultures (data not shown). These
results suggest that Wnt signaling contributes to increased cell
motility, which in turn may promote the invasiveness and/or
metastasis of prostate cancer cells.
Discussion
Role of Wnt signaling during prostate development
In this study, we investigated the role of Wnt signaling pathway
in the prostate first from a developmental biology perspective and
then as an extension, in a closely related pathogenic process, i.e,
tumorigenesis. The ex vivo postnatal prostatic tissue culture
experiments not only allows convenient monitoring of the effects
of growth factors or inhibitory agents on early prostate
Figure 4. TaqMan RT-PCR analyses of Axin2 expression during
prostate development and regrowth following androgen
deprivation and replacement. (A) A gradual downregulation of
Axin2 from newborn to adulthood. (B) Axin2 was upregulated following
castration, but returned to normal low levels after androgen
replacement. Data were collected from 4–6 samples per group and
are expressed as mean+SEM (t-test, compared to normal adult
prostates). Abbreviation: N, normal prostate; C3, 3 days after castration,
C17; 17 days after castration; C14+T. 14 days after castration+3 days of
testosterone treatment.
doi:10.1371/journal.pone.0002186.g004
Wnt and Prostate Development
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when the supply of reagents is fairly limited. This system has been
used previously in elucidating the role of androgenic hormones,
tissue components and various novel pathways in prostatic
branching morphogenesis and early development [17,18,28–30]
We have directly examined the role of Wnt signaling during
prostate development by using both Wnt signaling stimulating and
inhibitory factors, Wnt3a and DDK1, respectively. Addition of the
Wnt ligand, Wnt3a, results in enhanced cell proliferation and a
reduction of luminal epithelial cell differentiation, whereas
treatment with the Wnt pathway inhibitor, DKK1, enhanced cell
differentiation and reduced cell proliferation. Modulation of cell
proliferation by Wnt signaling can be attributed, in part, to altered
levels of cyclin B2, as cyclin molecules are previously reported to
play a role in prostate cell proliferation [31,32]. These data
together suggest that the requirement for the Wnt signaling in
prostate branching morphogenesis is tightly and delicately
regulated as both increased and decreased Wnt activity could
adversely affect prostate branching morphogenesis in ex vivo
cultures. Furthermore, our analysis of messenger RNA levels of
Axin2 and b-galactosidase expression in BAT-gal transgenic mice
as indicators of Wnt pathway activity in postnatal prostates also
suggest that Wnt pathway is more active in developing prostates
than mature prostates.
Association of Wnt signaling and prostate basal cells
where progenitor cells are generally believed to reside
Our findings from organ cultures of developing prostates are
consistent with the role of Wnt signaling in maintenance of
progenitor cells in other tissues such as the intestine [33],
mammary gland [34] and hematopoietic system [35]. In addition,
correlation of basal cells where progenitor cells are generally
believed to reside with activation of the Wnt pathway is also
observed during prostate re-growth following castration and
Figure 5. b-galactosidase expression in BAT-gal transgenic prostates. Double immunostaining of prostate tissue sections with anti-b-
galactosidase (green in A, D, G, J) and anti-p63 (red, in B, E, H, K) antibodies, prepared from mice of P5 (A-C), adult (D-F), 14 days post-castration (G-I)
and 14 days after androgen replacement (J-L). The sections were counterstaining with DAPI (blue). While arrows indicate cells that co-express p63 and
b-galactosidase, arrowhead (Fig. 1A-C) shows a cell that is b-gal positive but p63 negative in the developing prostate. Note that b-galactosidase-
expressing cells are located exclusively in the epithelium, and mainly within the basal cell compartment in the adult prostate, although a noticeable
number of the are seen in the luminal cell layer in developing prostate. Bar, 50 mm. (M) Quantification of b -gal positive cells per epithelial ductal unit,
which is determined in the tissue sections based on DAPI counterstaining and the presence of an epithelial lumen. (N) Cell counts of b -gal positive
cells over total basal cells (p63 positive cells). Data were collected from 14–20 randomly selected ductal units in the sections from 4–5 prostates per
group and are expressed as mean+SEM (t-test, compared to normal adult prostates).
doi:10.1371/journal.pone.0002186.g005
Figure 6. Wnt signaling is activated in prostate cancer cells.
TaqMan RT-PCR analysis of Axin2 expression in various human prostate
epithelial cells and cancer cells. Data were collected from triplets and
are expressed as mean+SEM (t-test). Note that Axin2 expression is much
higher in prostate cancer cell lines (LNCaP, Du145, PC3) and human
prostate tumor xenografts (LuCaP35, LuCaP77) as compared to primary
prostate epithelial cells (PrEC) or non-tumorigenenic immortalized
prostate epithelial cells (BPH1).
doi:10.1371/journal.pone.0002186.g006
Figure 7. DKK1 inhibits proliferation and migration of prostate
cancer cells. (A) Tritiated thymidine incorporation in PC3 cultures in
the absence or presence of Wnt3a or DKK1. While high concentration of
Wnt3a (10nM) enhanced PC3 cell proliferation, DKK1 inhibited PC3
proliferation in a dose-dependent manner. (B) Regulation of PC3 cell
migration by Wnt signaling. Data were collected from 6–8 cultures per
group and are expressed as mean+SEM (t-test). Note that Wnt3a
increased the number of migrated cells, whereas DKK1 inhibited cell
migration.
doi:10.1371/journal.pone.0002186.g007
Wnt and Prostate Development
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are independent of androgen for survival. Accordingly, previous
studies have shown that following castration, the prostate epithelial
progenitor cell population is enhanced or enriched [30,36,37] due
to apoptosis of androgen-dependent, terminally differentiated
luminal epithelial cell population. Conversely, when androgen is
replaced the prostate is triggered to re-grow to its original size
attributable to enhanced proliferation of progenitor cells and their
subsequent differentiation into new luminal cells. Using Axin2 as a
molecular indicator, we found that Wnt is upregulated following
castration but is down-regulated after androgen replacement,
corresponding nicely with the content of progenitor cells in the
prostate. Similar dynamic pattern of Wnt activity was seen in
BAT-gal transgenic mice. Suppression of the Wnt signaling
pathway after hormonal replacement, as indicated by the down-
regulation of Axin2 mRNA or reduced number of b-galactosidase-
positive cells may be due to an interaction between b-catenin and
AR pathway. b-catenin has been shown able to interact with AR
and functions as a co-activator of AR [38]. It is possible that
following ligand binding, the active form of AR, in addition to its
normal function as a transcription factor for prostate development,
also binds and sequesters nuclear b-catenin, leading to a reduction
in the pool of b-catenin available for b-catenin-TCF trans-
activation [38]. As a result of reduced Wnt signaling, prostate
progenitor cells would then be induced to differentiate into luminal
cells. Taken together, these findings provide supportive evidence
for the role of Wnt signaling in progenitor cell maintenance in the
prostate epithelium.
Implications of Wnt signaling in prostate cancer cell
growth
Increasing evidence suggests that the Wnt pathway may also
contribute to prostate cancer progression [39]. Several Wnt ligand
including Wnt1 and Wnt2 are up-regulated in human prostate
tumor samples [40,41]. sFRP3 can suppress prostate tumor cell
growth and invasion [42]. Dkk3 has recently been shown to be
down-regulated in human prostate tumor samples, and DKK1
treatment can inhibit prostate tumor cell growth [43]. More lately, it
is reported that adenocarcinomas are formed in a prostate-specific
APC deletion mouse model [10]. Our study indicates that Axin2 is
elevated in several human prostate cancer cell lines and xenograft
human prostate tumors as compared to normal human PrEC and
non-tumorigenic immortalized human prostate epithelial cells,
providing further support for an oncogenic role for Wnt pathway
activation in prostate tumorigenesis. In addition, our finding that
DKK1 treatment significantly inhibits prostate cancer cell growth
and migration reinforces this notion. Due to inherent difficulties
associated with the production and purification of a large quantity of
DKK1 required for in vivo xenograft experiments, the in vivo
prostate cancer xenograft experiment has not been performed, but is
warranted in the future to confirm the inhibitory effects on DKK1
on prostate tumor growth and progression.
A cancer stem cell model has recently been proposed for many
cancer types. In the case of prostate cancer, cancer stem cells are
those that are believed to be independent of androgen for survival.
Given the fact the Wnt signaling is important for cell proliferation
and differentiation during normal development and is associated
with the basal cells where progenitor cells are generally believed to
reside during re-growth following castration and androgen
replacement, it would be interesting to determine if Wnt pathway
is also associated with prostate cancer stem cells that may play a
crucial role in androgen resistance and late stage prostate cancer
progression. Isolation of prostate cancer cells that express receptors
for Wnt ligands to perform tumorigenicity as well as stem cell
property studies would help answer this question and provide
insight into whether Wnt signaling is associated with prostate
cancer stem cells. If so, this may highlight targeting prostate cancer
stem cells as an alternative mechanism of action of Wnt pathway
inhibitors in the treatment of prostate cancer.
In summary, to our knowledge, this is the first report to show
that Wnt signaling regulates prostatic epithelial branching
morphogenesis via influencing cell proliferation and differentiation
in the epithelium. Consistent with other studies [10,11,40,41,43],
activation of the Wnt pathway contributes to prostate cancer
progression. Inhibition of Wnt pathway might therefore be of
therapeutic value in the management of prostate cancer.
Materials and Methods
Organ culture of prostate tissue
Ventral prostates were dissected from postnatal day 2 (P2) rats
and placed on 8-mm cell culture inserts (BD Biosciences) in serum-
free medium containing Dulbecco’s modified Eagle’s medium/F-
12 plus serum-free supplement (I-1884; Sigma), 1% bovine serum
albumin, 2 mM glutamine, 5 mg/ml glucose, 25 ng/ml fungizone,
and 100 units/ml penicillin and 100 mg/ml streptomycin, as
previously [18]. Wnt3a (50 nM, R&D), and DKK1 (400 nM,
Genentech, Inc) were added to the serum-free medium in the
experimental groups at the beginning of organ cultures. The
medium was changed every other day. In some cultures,
bromodeoxyuridine (BrdU, Amersham, 1:1000) was added on
the third day for 2 hr before the cultures were fixed in 4%
paraformaldehyde (30min). The other cultures were fixed in ice-
cold methanol for 15 mins at room temperature prior to
processing for immunohistochemistry.
Cell culture, 3H-thymidine incorporation and Migration
assays
The PC3 cell line was purchased from ATCC and maintained
in Dulbecco’s modified Eagle’s medium/F-12 plus 10% fetal
bovine serum (Sigma). For 3H-thymidine incorporation assays,
cells were plated at 4000 cells/well in a 96-well plate in serum free
medium with either Wnt3a (5 nM or 10 nM) or DKK1 (100nM or
400 nM) for 24 hours. 3H-thymidine (1 mCi/well) was added for
16 hours, and cells were harvested using a Tomtec cell harvester.
Incorporated H3-tymidine was counted with TOP Count
(Pachard Instrument Company, Meriden, CT) as described [44].
Each of the experimental groups had 8–12 replicates, and the data
were expressed as mean6SEM. A two-tailed, unpaired t test was
used for statistical analysis. For migrating assay, cells were plated
at 5610
4/ml for 24-well chambers (#354480, BD Biosciences) in
0.5 ml of Dulbecco’s modified Eagle’s medium/F-12 plus 10%
fetal bovine serum for 22 hours. The cells on the upper surface of
the membrane were removed by scrubbing; the cells on the lower
surface of the membrane were fixed with 100% methanol, stained
with H & E, photographed and counted.
Prostate regrowth following hormone replacement
Mice at the age of 12–14 weeks old were castrated as described
[30]. Some mice were implanted with testosterone pellets (15 mg/
pellet/mouse, Innovative Research, Sarasota, FL) for 3 or 14 days
after 14-day post-castration. Mice were euthanized and prostates
were harvested at 3 or 17 days after castration. Some of the
experiments were also performed with BAT-gal transgenic mice
[25]. All animal experiments were performed in accordance with
approved guidelines of institutional animal care and use
committee at Genentech.
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Five-micrometer sections of prostate cultures/tissue were stained
with anti-p63 antibody (1:200 dilution; Santa Cruz Biotechnology),
anti-b2galactosidase (1:10,000, MP Biomedical), anti-BrdU (1:40,
BD Biosciences), or Ki67 antibody (1:50 dilution, DAKO,
Carpinteria, CA) followed with AlexFluor 594 goat anti-rabbit
secondary antibody (Invitrogen. Carlsbad, CA) and/or AlexFluor
488 goat anti-mouse IgG (Invitrogen). The slides were mounted in
Fluoromount-G (Southern Biotechnology) containing counter stain-
ing dye 49,6-diamidino-2-phenylindole (Sigma) and viewed using a
Zeiss Axiophot epifluorescent microscope. Images were captured
with Compix imaging systems using a cooled RGB CCD camera
and analyzed using Adobe PhotoShop 7.0. Cell counting was
performed on digital images acquired from the slides. At least five
randomly selected regions from different sections were counted for
each group; and two-tailed, unpaired t-test was applied for statistical
analysis. Data are expressed as mean6SEM.
TaqMan real-time quantitative RT-PCR
TaqMan real-time quantitative PCR (RT-PCR) analysis was
performed as described [45]. The following specific probes and
primers were used for human Axin2 (probe, TGCCTCCTG-
GTCACACGAACAATGG; forward primer, CTCCAAGTGT-
CGTCCGGTTT; reverse primer, TGTACTCCGAGTCG-
GAATC), mouse Axin2 (probe, CCCAACGCGCCCTCTTT-
GATCTG; forward primer, TGGCTTTGACTACGCCCAC;
reverse primer, GGGAGCTGAAGCGCTGG), rat Axin2 (probe
TGTGAACAGTGCCAGGAGAGCGGT; forward primer,
CCTGGATGTGCGGATTGC; reverse primer, TGCCCAG-
GAGCACTAGGC), and rat cyclin B2 (Applied Biosystems
probe# Pr006906188.1). Probes and primers for the control
housekeeping gene Gapdh were the same as reported [44].
Expression levels of genes of interest were normalized to gapdh.
Initial RT-PCR amplifications were also examined by agarose gel
electrophoresis to ensure that bands were only visible at the
expected molecular weights.
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